Atul J. Butte
Fondateur chez NuMedii, Inc.
Profil
Atul J.
Butte is the founder of Personalis, Inc. founded in 2011, Carmenta Bioscience, Inc. founded in 2012, and NuMedii, Inc. founded in 2008 where he holds the title of Director starting in 2008.
Postes actifs de Atul J. Butte
| Sociétés | Poste | Début |
|---|---|---|
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Fondateur | 01/01/2008 |
Anciens postes connus de Atul J. Butte
| Sociétés | Poste | Fin |
|---|---|---|
Carmenta Bioscience, Inc.
 Carmenta Bioscience, Inc. Medical SpecialtiesHealth Technology Carmenta Bioscience, Inc. provides biotechnology services. It offers technology that medical need in maternal and fetal health. The company was founded by Matthew Cooper, Atul J. Butte, and Bruce Ling in 2012 and is headquartered Palo Alto, CA. | Fondateur | - |
| PERSONALIS, INC. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PERSONALIS, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
Carmenta Bioscience, Inc.
Carmenta Bioscience, Inc. Medical SpecialtiesHealth Technology Carmenta Bioscience, Inc. provides biotechnology services. It offers technology that medical need in maternal and fetal health. The company was founded by Matthew Cooper, Atul J. Butte, and Bruce Ling in 2012 and is headquartered Palo Alto, CA. | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Commercial Services |